Selected-Lesion SRS as a Novel Strategy in Treatment of Patients with Multiple Brain Metastases

C. Singh, B. C. Theriault,Y. An,J. B. Yu,J. P. S. Knisely, M. Shepard, R. E. Wegner,R. E. Warnick,S. Peker, Y. Samanci, D. M. Trifiletti,C. C. Lee, H. C. Yang,K. Bernstein,D. Kondziolka,M. Tripathi,D. Mathieu,G. Mantziaris,S. Pikis,J. P. Sheehan, V. L. Chiang

International journal of radiation oncology, biology, physics(2023)

引用 0|浏览1
暂无评分
摘要
The responses to this survey demonstrate that patients with >15-20 intracranial lesions, prior WBRT, and worsening systemic disease with CNS penetrating systemic therapies available are being considered for SL-SRS.
更多
查看译文
关键词
selected-lesion
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要